AnnouncedFiled 18 August 2025
Rezo Therapeutics, Inc. has sold $68.1M so far
Rezo Therapeutics, Inc., a biotech company based in San Francisco, CA, has sold $68.1M so far in its equity round, according to a filing dated 18 August 2025.
Announced on 17 November 2022, 1,005 days before the filing. rezotx.com ↗
- Filed
- 18 August 2025
- First filed
- 1 December 2022
- Round
- Equity round (amended filing)
- Amount sold
- $68.1M
- Offering size
- $80.1M
- Investors so far
- 21
- Based in
- San Francisco, CA
- Website
- rezotx.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 92% of the 1,404 tracked raises with an amount filed in 2025, and than 85% of the 112 in biotech.
Rezo Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 18 Aug 2025 | Amended filing | $68.1M | This raise |
| 1 Dec 2022 | New filing | $14.6M | This raise |
More with SR One Capital on the board
- FORE US Bio Inc.$70.4M
- Avenzo Therapeutics, Inc.$47.2M
- ADARx Pharmaceuticals, Inc.$200M
- Dren Bio, Inc.$62.5M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.